- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 98.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 100.6M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 96.3M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$197M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$166M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $175M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $421M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $127M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$236M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$80M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $144M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $255M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $325M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $384M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.53B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.61B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $657M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $951M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.3B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.53B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.84 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.57 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.84 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.57 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $88M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $87M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $187M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $166M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$185M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$151M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$169M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$143M |
| Revenue | Q1 2026 · Mar 31, 2026 | $136M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $139M |